3 results
Approved WMOCompleted
The primary objective of this study is to determine whether the Impella cVAD device vs. IABP therapy leads to a higher 30 day survival rate in shock STEMI patients in the setting of primary PCI.
Approved WMOCompleted
to assess patient's overall preference for the two inhaler devices in COPD patients after 2 weeks of dialy practice.
Approved WMOCompleted
3 year post market clinical follow-up study